Process View
The chemical reactions and pathways resulting in the breakdown of leukotriene B4, a leukotriene composed of (6Z,8E,10E,14Z)-eicosatetraenoic acid having (5S)- and (12R)-hydroxy substituents.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "leukotriene b4 catabolic process"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.951 | ||
CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.870 | ||
CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.538 | Human | |
CYP4F3 | cytochrome P450, family 4, subfamily F, polypeptide 3 | 0.517 | Human | |
CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.423 | ||
CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 0.243 | ||
CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.192 | ||
CYP4F11 | cytochrome P450, family 4, subfamily F, polypeptide 11 | 0.161 | Human | |
FABP1 | fatty acid binding protein 1, liver | 0.128 | ||
CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 0.090 | ||
CYP3A5 | cytochrome P450, family 3, subfamily A, polypeptide 5 | 0.081 | ||
KNG1 | kininogen 1 | 0.077 | ||
SULT1B1 | sulfotransferase family, cytosolic, 1B, member 1 | 0.058 | ||
C4BPA | complement component 4 binding protein, alpha | 0.057 | ||
HAL | histidine ammonia-lyase | 0.055 | ||
ADH6 | alcohol dehydrogenase 6 (class V) | 0.053 | ||
G6PC | glucose-6-phosphatase, catalytic subunit | 0.051 | ||
HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | 0.050 | ||
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | 0.047 | ||
ARG1 | arginase, liver | 0.046 | ||
C8A | complement component 8, alpha polypeptide | 0.045 | ||
SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.036 | ||
SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.035 | ||
AZGP1 | alpha-2-glycoprotein 1, zinc-binding | 0.035 | ||
F9 | coagulation factor IX | 0.031 | ||
CYP2C18 | cytochrome P450, family 2, subfamily C, polypeptide 18 | 0.031 | ||
DAO | D-amino-acid oxidase | 0.031 | ||
ADH1C | alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.029 | ||
MAT1A | methionine adenosyltransferase I, alpha | 0.029 | ||
AADAC | arylacetamide deacetylase (esterase) | 0.029 | ||
SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 0.028 | ||
PLG | plasminogen | 0.028 | ||
CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.028 | ||
UGT1A3 | UDP glucuronosyltransferase 1 family, polypeptide A3 | 0.024 | ||
RDH16 | retinol dehydrogenase 16 (all-trans) | 0.023 | ||
OTC | ornithine carbamoyltransferase | 0.022 | ||
HRG | histidine-rich glycoprotein | 0.022 | ||
BHMT | betaine--homocysteine S-methyltransferase | 0.021 | ||
SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.020 | ||
SLC22A7 | solute carrier family 22 (organic anion transporter), member 7 | 0.020 | ||
FETUB | fetuin B | 0.019 | ||
PAH | phenylalanine hydroxylase | 0.019 | ||
CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 0.018 | ||
EPHX2 | epoxide hydrolase 2, cytoplasmic | 0.018 | ||
CDHR5 | cadherin-related family member 5 | 0.018 | ||
CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 | 0.017 | ||
SLC22A1 | solute carrier family 22 (organic cation transporter), member 1 | 0.017 | ||
HGD | homogentisate 1,2-dioxygenase | 0.017 | ||
GSTA3 | glutathione S-transferase alpha 3 | 0.017 | ||
APOC3 | apolipoprotein C-III | 0.017 | ||
GLYAT | glycine-N-acyltransferase | 0.017 | ||
APOF | apolipoprotein F | 0.017 | ||
CEACAM6 | carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | 0.016 | ||
TMPRSS4 | transmembrane protease, serine 4 | 0.016 | ||
MASP2 | mannan-binding lectin serine peptidase 2 | 0.016 | ||
C8G | complement component 8, gamma polypeptide | 0.016 | ||
F13B | coagulation factor XIII, B polypeptide | 0.016 | ||
DEFB1 | defensin, beta 1 | 0.016 | ||
IL22RA1 | interleukin 22 receptor, alpha 1 | 0.016 | ||
SULT1E1 | sulfotransferase family 1E, estrogen-preferring, member 1 | 0.015 | ||
CYP4B1 | cytochrome P450, family 4, subfamily B, polypeptide 1 | 0.015 | Human | |
PIP | prolactin-induced protein | 0.015 | ||
CEACAM8 | carcinoembryonic antigen-related cell adhesion molecule 8 | 0.015 | ||
CPB2 | carboxypeptidase B2 (plasma) | 0.015 | ||
SEC14L2 | SEC14-like 2 (S. cerevisiae) | 0.015 | ||
HPD | 4-hydroxyphenylpyruvate dioxygenase | 0.015 | ||
CYP2J2 | cytochrome P450, family 2, subfamily J, polypeptide 2 | 0.015 | ||
C8B | complement component 8, beta polypeptide | 0.015 | ||
HAO1 | hydroxyacid oxidase (glycolate oxidase) 1 | 0.015 | ||
NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | 0.014 | ||
ORM1 | orosomucoid 1 | 0.014 | ||
SCNN1A | sodium channel, nonvoltage-gated 1 alpha | 0.014 | ||
GBA3 | glucosidase, beta, acid 3 (cytosolic) | 0.014 | ||
AKR1C4 | aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) | 0.014 | ||
AKR1D1 | aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase) | 0.014 | ||
BAAT | bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) | 0.014 | ||
PIPOX | pipecolic acid oxidase | 0.014 | ||
C9 | complement component 9 | 0.013 | ||
APOC4 | apolipoprotein C-IV | 0.013 | ||
KRT13 | keratin 13 | 0.013 | ||
FMO4 | flavin containing monooxygenase 4 | 0.013 | ||
PRLR | prolactin receptor | 0.013 | ||
DIO1 | deiodinase, iodothyronine, type I | 0.012 | ||
LIPC | lipase, hepatic | 0.012 | ||
CYP8B1 | cytochrome P450, family 8, subfamily B, polypeptide 1 | 0.012 | ||
LPA | lipoprotein, Lp(a) | 0.012 | ||
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | 0.012 | ||
CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 0.012 | ||
CFHR4 | complement factor H-related 4 | 0.011 | ||
SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | 0.011 | ||
FABP2 | fatty acid binding protein 2, intestinal | 0.011 | ||
SLC25A47 | solute carrier family 25, member 47 | 0.011 | ||
F5 | coagulation factor V (proaccelerin, labile factor) | 0.011 | ||
AKR1B10 | aldo-keto reductase family 1, member B10 (aldose reductase) | 0.011 | ||
LECT2 | leukocyte cell-derived chemotaxin 2 | 0.011 | ||
GSTT1 | glutathione S-transferase theta 1 | 0.011 | ||
CRISP3 | cysteine-rich secretory protein 3 | 0.011 | ||
NAT8 | N-acetyltransferase 8 (GCN5-related, putative) | 0.010 | ||
HPX | hemopexin | 0.010 | ||
PLEKHG6 | pleckstrin homology domain containing, family G (with RhoGef domain) member 6 | 0.010 | ||
PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 0.010 | ||
CRP | C-reactive protein, pentraxin-related | 0.010 | ||
GPT | glutamic-pyruvate transaminase (alanine aminotransferase) | 0.010 | ||
DPYS | dihydropyrimidinase | 0.010 | ||
HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 | 0.010 | ||
APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.010 |